CAMP Q4 2024 Earnings — CAMP4 Therapeutics Corporation Revenue & Financial Results | Market Cap Arena

CAMPCAMP4 Therapeutics Corporation

$125M

Q4 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$652,000

Gross Profit

$652,000100.0% margin

Operating Income

-$14M-2152.5% margin

Net Income

-$13M-2036.7% margin

EPS (Diluted)

$-0.68

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$11M

Free Cash Flow

-$12M

Stock-Based Comp.

$797,000

Balance Sheet

Total Assets

$78M

Total Liabilities

$15M

Stockholders' Equity

$63M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$652,000	$0	—
Gross Profit	$652,000	$0	—
Operating Income	-$14M	-$13M	-4.1%
Net Income	-$13M	-$13M	-2.2%